Back to search
FDAFDA · Food and drugs·Recall number Z-1163-2025

Microbiologics Multi-Strain Human Papillomavirus (HPV) Control Panel (Inactivated Pellet), REF 8234; in-vitro diagnostic test

Published February 19, 2025 · Recall initiated: January 20, 2025

Summary

FDA records medical device Class II recall Z-1163-2025, published February 19, 2025 and initiated January 20, 2025. Recalling firm: Microbiologics Inc; Status: Ongoing; Reported quantity: 16 units; Lot: UDI/DI 70845357043077, Lot Number 8234-22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Microbiologics Inc
Distributor
Worldwide distribution - US Nationwide and the countries of Netherlands, Sweden, UK, France, Australia, New Zealand.
Lot
UDI/DI 70845357043077, Lot Number 8234-22
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Microbiologics Multi-Strain Human Papillomavirus (HPV) Control Panel (Inactivated Pellet), REF 8234; in-vitro diagnostic test recalled?

Yes. FDA published recall Z-1163-2025 on February 19, 2025. Reported hazard: Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail